Centrient Pharmaceuticals* awarded second independent Minimized Risk of Antimicrobial Resistance (AMR) certification for Toansa, India Site
Centrient continues to be a leader in the industry in minimizing the risk of antimicrobial resistance (AMR), actively shaping and meeting the independent standards now adopted across the sector.
Sustainability is at the heart of our daily decisions and integral to our strategic vision leading up to 2030. It underscores our purpose of enhancing the well-being of patients worldwide. In navigating the complex landscape of choices, we focus on areas where our actions can exert the greatest influence.
